CD274 and melanoma: Beyond canonical oncogenic mutations, recent transcriptomic and proteomic analyses have revealed that immune-related gene alterations—such as upregulation of PD-L1, downregulation of MHC class I molecules, and altered cytokine signaling networks—play central roles in defining the aggressiveness of canine melanomas.